Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer
出版年份 2012 全文链接
标题
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer
作者
关键词
-
出版物
BMC CANCER
Volume 12, Issue 1, Pages -
出版商
Springer Nature
发表日期
2012-10-02
DOI
10.1186/1471-2407-12-447
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
- (2012) Nathan W. D. Lamond et al. BREAST CANCER RESEARCH AND TREATMENT
- Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
- (2011) J. Huober et al. BREAST
- Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba
- (2011) C. L. Baunemann Ott et al. Current Oncology
- Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03)
- (2010) Masahide Kondo et al. BREAST CANCER RESEARCH AND TREATMENT
- Radiation treatment waiting times for breast cancer patients in Manitoba, 2001 and 2005
- (2010) A.L. Cooke et al. Current Oncology
- Health economics in drug development: Efficient research to inform healthcare funding decisions
- (2010) Peter S. Hall et al. EUROPEAN JOURNAL OF CANCER
- Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
- (2010) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
- (2010) Shelly S. Lo et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer
- (2010) Miguel Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
- (2010) D. T. Tsoi et al. ONCOLOGIST
- Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
- (2010) Shmuel H. Klang et al. VALUE IN HEALTH
- How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma
- (2010) Isabelle Chabot et al. VALUE IN HEALTH
- Comparison of Treatment Received Versus Long-Standing Guidelines for Stage III Colon and Stage II/III Rectal Cancer Patients Diagnosed in Alberta, Saskatchewan, and Manitoba in 2004
- (2009) Marilyn Cree et al. Clinical Colorectal Cancer
- Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
- (2008) Juhi Asad et al. AMERICAN JOURNAL OF SURGERY
- Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada
- (2008) Noemi Muszbek et al. CURRENT MEDICAL RESEARCH AND OPINION
- Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial
- (2008) Jo Anne Zujewski et al. Future Oncology
- Docetaxel in Combination With Doxorubicin and Cyclophosphamide As Adjuvant Treatment for Early Node-Positive Breast Cancer: A Cost-Effectiveness and Cost-Utility Analysis
- (2008) Sorrel E. Wolowacz et al. JOURNAL OF CLINICAL ONCOLOGY
- Histopathologic variables predict Oncotype DX™ Recurrence Score
- (2008) Melina B Flanagan et al. MODERN PATHOLOGY
- The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond
- (2008) Angela Rocchi et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now